Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 May 8;38(3):BSR20171672.
doi: 10.1042/BSR20171672. Print 2018 Jun 29.

Interferon regulatory factor 1 inactivation in human cancer

Affiliations
Review

Interferon regulatory factor 1 inactivation in human cancer

Khaldoon Alsamman et al. Biosci Rep. .

Abstract

Interferon regulatory factors (IRFs) are a group of closely related proteins collectively referred to as the IRF family. Members of this family were originally recognized for their roles in inflammatory responses; however, recent research has suggested that they are also involved in tumor biology. This review focusses on current knowledge of the roles of IRF-1 and IRF-2 in human cancer, with particular attention paid to the impact of IRF-1 inactivation. The different mechanisms underlying IRF-1 inactivation and their implications for human cancers and the potential importance of IRF-1 in immunotherapy are also summarized.

Keywords: Cancer; Interferon Regulatory Factor; Oncogene; Tumor Suppressor.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no competing interests associated with the manuscript.

Figures

Figure 1
Figure 1. Illustration of the various functional domains of IRF family members
All IRF family members contain a DBD (blue) and a regulatory domain (light blue). In addition, most IRFs possess a type 1 (dark green) or type 2 (light green) IAD. A repression domain that functions to repress gene expression (purple) is also present in some IRF family members. Finally, a nuclear localization signal domain (orange) is found in most IRFs.
Figure 2
Figure 2. The anti- and pro-oncogenic activity of IRF-1 and IRF-2
IRF-1 anti-oncogenic activity is attributed to four main mechanisms: (I) Derailing of cell cycle; (II) Down-regulation of growth promoting genes; (III) Induction of tumor suppressor genes, and (IV) Up-regulation of apoptotic machinery. The pro-oncogenic potential of IRF-2 is owed to: (i) Suppression of IRF-1 activity; (ii) up-regulation of growth promoting genes, and (iii) supporting oncogenes-induced growth.
Figure 3
Figure 3. Signal transduction pathway and cross-talk in the interferon system
Stimulation of type I and II interferon receptor recruits Janus and tyrosine kinases that phosphorylates and activates STAT. STAT proteins trigger nuclear translocation of IRF members where they interact with ISRE to regulate expression of ISG resulting in various physiological responses.

References

    1. Miyamoto M., et al. (1988) Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-beta gene regulatory elements. Cell 54, 903–913 10.1016/S0092-8674(88)91307-4 - DOI - PubMed
    1. Harada H., et al. (1989) Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell 58, 729–739 10.1016/0092-8674(89)90107-4 - DOI - PubMed
    1. Meraro D., et al. (1999) Protein-protein and DNA-protein interactions affect the activity of lymphoid-specific IFN regulatory factors. J. Immunol. 163, 6468–6478 - PubMed
    1. Taniguchi T., et al. (2001) IRF family of transcription factors as regulators of host defense. Annu. Rev. Immunol. 19, 623–655 10.1146/annurev.immunol.19.1.623 - DOI - PubMed
    1. Yanai H., Negishi H. and Taniguchi T. (2012) The IRF family of transcription factors: Inception, impact and implications in oncogenesis. Oncoimmunology 1, 1376–1386 10.4161/onci.22475 - DOI - PMC - PubMed

MeSH terms

Substances

LinkOut - more resources